Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial

Journal:
The Lancet
Published:
Affiliations:
23
Authors:
24
Institutions Authors Share
Abbisko Therapeutics, China
3.000000
0.13
Beijing Jishuitan Hospital, China
2.000000
0.08
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.04
Princess Margaret Cancer Centre, U of T, Canada
1.000000
0.04
McGill University Health Centre (MUHC), Canada
1.000000
0.04
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China
1.000000
0.04
The First Affiliated Hospital, SYSU, China
1.000000
0.04
Second Xiangya Hospital, CSU, China
1.000000
0.04
Precision NextGen oncology and Research Center, United States of America (USA)
1.000000
0.04
Vall d'Hebron University Hospital (HUVH), ICS, Spain
1.000000
0.04
IRCCS National Cancer Institute (INT) Milan, Italy
1.000000
0.04
Hunan Provincial People's Hospital, China
1.000000
0.04
Hospital of Prato, Italy
1.000000
0.04
Second Affiliated Hospital of Shanxi Medical University, SXMU, China
1.000000
0.04
Shanghai General Hospital, SJTU, China
1.000000
0.04
Zhejiang Cancer Hospital (ZJCH), China
1.000000
0.04
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
1.000000
0.04
Liaoning Cancer Hospital and Institute, China
1.000000
0.04
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
1.000000
0.04
Leiden University Medical Center (LUMC), Netherlands
1.000000
0.04
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain
0.666667
0.03
Hospital Universitario General de Villalba, Spain
0.333333
0.01